NIH-funded research R01 grant

Understanding how microRNA decay affects blood cell development

Official title: Mechanisms and relevance of miRNA decay during hematopoietic development

Funded at Washington University · NIH-10941648 · Data updated 2026-11-12

This study is looking at how tiny molecules called microRNAs affect the way our blood cells are made, especially when certain genes are changed, and it hopes to help people with blood disorders like bone marrow failure by finding out more about these processes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startAugust 1, 2024
Project endJuly 31, 2028
Funding year2024
Award (this year)$657,368
NIH project number1R01HL174789-01
Project IDNIH-10941648 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals with genetic mutations affecting blood cell development or those diagnosed with blood disorders.

Less likely to help

Patients with unrelated health conditions or those not affected by blood cell development issues may not receive any benefit from this research.

What this research studies

This research investigates the role of microRNAs (miRNAs) in the development of blood cells, focusing on how their degradation impacts hematopoiesis. By studying human pluripotent stem cells with specific genetic mutations, the research aims to uncover the molecular pathways that regulate miRNA processing and degradation. This could lead to a better understanding of blood cell formation and the underlying mechanisms of related disorders. Patients may benefit from insights gained into conditions like bone marrow failure syndromes.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for blood disorders caused by miRNA dysregulation.

How similar studies have gone: Previous research has shown that understanding miRNA functions can lead to significant advancements in treating blood-related conditions, indicating a promising avenue for this investigation.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Batista, Luis Francisco Zirnberger — Washington University
  • Study coordinator: Batista, Luis Francisco Zirnberger

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.